Newsletter Archive

  1. 10.18.17 -- How To Break The Pharmaceutical 2-3 Sigma Barrier (Like Amgen)
    10/18/2017
    10/18/17 BioProcess Online Newsletter
  2. 10.16.17 -- Is It Time For A Standardized CMC Knowledge Base?
    10/16/2017
    10/16/17 BioProcess Online Newsletter
  3. 10.11.17 -- Can New York City Lead In Life Sciences?
    10/11/2017
    10/11/17 BioProcess Online Newsletter
  4. 10.09.17 -- Can Biosimilars Increase The Profitability Of Generics Manufacturers?
    10/9/2017
    10/09/17 BioProcess Online Newsletter
  5. 10.05.17 -- Microbial Contamination 101: Identifying & Controlling Sources Of Bioburden
    10/5/2017
    10/05/17 BioProcess Online Newsletter
  6. 10.04.17 -- Biocontainment: An Introduction To Control Levels & Practical Design Concepts
    10/4/2017
    10/04/17 BioProcess Online Newsletter
  7. 10.02.17 -- How Biosimilar Companies Can Survive An Uncertain Future
    10/2/2017
    10/02/17 BioProcess Online Newsletter
  8. 09.27.17 -- Why You Need A Quality Culture: And How To Attain It
    9/27/2017
    09/27/17 BioProcess Online Newsletter
  9. 09.25.17 -- Brexit & The Biopharma Industry: 3 Important Developments To Watch
    9/25/2017
    09/25/17 BioProcess Online Newsletter
  10. 09.21.17 -- Single-Use Bioreactor Streamlines Bioprocessing
    9/21/2017
    09/21/17 BioProcess Online Newsletter